On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Fondazione Per L'Istituto di Ricerca In Biomedicina's own share of each project, not the project's full budget.
- Horizon 2020€11.5M · 9 projects
- FP7 (2007 to 2013)€8.0M · 13 projects
- Horizon Europe€3.3M · 5 projects
Projects
27 EU-funded projects, newest first. Fondazione Per L'Istituto di Ricerca In Biomedicina led 11 of them as coordinator. Each links to the official record.
- MISMATCHCoordinator
Pathological and physiological roles of the MutL-gamma (MLH1-MLH3) nuclease: from harmful trinucleotide repeat expansions to promoting diversity in meiosis
Horizon Europe · 2027–2032 · Project on CORDIS ↗
€3.3Mtheir share - T-RAFICAssociated partner
Training network for tracking and controlling therapeutic immune cells in cancer
Horizon Europe · 2025–2029 · Project on CORDIS ↗
- IMMERGEAssociated partner
Storming Immune Monogenic Conditions through Multiomic and Gene Editing Approaches
Horizon Europe · 2024–2027 · Project on CORDIS ↗
- TOP-GUTAssociated partner
Training for Organoids modelling Physiology and Pathology in the human gastrointestinal tract
Horizon Europe · 2023–2027 · Project on CORDIS ↗
- BRCA INSIGHTSCoordinator
Understanding the functions of the BRCA protein complexes in DNA break repair and in replication stress
Horizon 2020 · 2022–2027 · Project on CORDIS ↗
€1.9Mtheir share - ISIDORePartner
Integrated Services for Infectious Disease Outbreak Research
Horizon Europe · 2022–2025 · Project on CORDIS ↗
€43ktheir share - ATACPartner
Antibody therapy against coronavirus (COVID-19)
Horizon 2020 · 2020–2023 · Project on CORDIS ↗
€3.9Mtheir share - TIL-FITCoordinator
Increasing the fitness of tumor-infiltrating T cells for cellular immunotherapy
Horizon 2020 · 2019–2023 · Project on CORDIS ↗
€1.4Mtheir share - TANTUMorNEUVACCINECoordinator
Neutrophil subtypes: distinct cellular targets for therapeutic intervention
Horizon 2020 · 2017–2020 · Project on CORDIS ↗
€266ktheir share - €183ktheir share
- HRMECHCoordinator
Nucleases in homologous recombination: from basic principles to genome editing
Horizon 2020 · 2016–2022 · Project on CORDIS ↗
€2.0Mtheir share - ZIKAlliancePartner
A global alliance for Zika virus control and prevention
Horizon 2020 · 2016–2021 · Project on CORDIS ↗
- EHVAPartner
European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates
Horizon 2020 · 2016–2023 · Project on CORDIS ↗
- BROADimmuneCoordinator
Structural, genetic and functional analyses of broadly neutralizing antibodies against human pathogens
Horizon 2020 · 2015–2020 · Project on CORDIS ↗
€1.9Mtheir share - IRINVACCoordinator
IMMUNE RESPONSES TO INFLUENZA VACCINE
FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗
€100ktheir share - PREDICTCoordinator
Dissecting the human T cell response to pathogens, allergens, and self-antigens
FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗
€2.5Mtheir share - LINFOEPABCoordinator
CD4 T AND B LYMPHOCYTES IN HEPATITIS B PATIENTS: ROLE IN ACUTE AND CHRONIC INFECTION
FP7 (2007 to 2013) · 2012–2014 · Project on CORDIS ↗
€248ktheir share - ABIRISKPartner
Anti-Biopharmaceutical Immunization:Prediction and analysis of clinical relevance to minimize the risk
FP7 (2007 to 2013) · 2012–2018 · Project on CORDIS ↗
€730ktheir share - TIMERPartner
TargetIng novel MEchanisms of Resolution in inflammation
FP7 (2007 to 2013) · 2012–2015 · Project on CORDIS ↗
€364ktheir share - €521ktheir share
- IDAMSPartner
International Research Consortium on Dengue Risk Assessment, Management, and Surveillance
FP7 (2007 to 2013) · 2011–2017 · Project on CORDIS ↗
€290ktheir share - RADARPartner
Rationally Designed Aquatic Receptors integrated in label-free biosensor platforms for remote surveillance of toxins and pollutants
FP7 (2007 to 2013) · 2011–2014 · Project on CORDIS ↗
€284ktheir share - IMMUNEXPLORECoordinator
New approaches to analyze and exploit the human B and T cell response against viruses
FP7 (2007 to 2013) · 2010–2015 · Project on CORDIS ↗
€2.0Mtheir share - NEWTBVACPartner
Discovery and preclinical development of new generation tuberculosis vaccines
FP7 (2007 to 2013) · 2010–2014 · Project on CORDIS ↗
€142ktheir share - MD-THIVCoordinator
Migration and Differentiation of Th17 Cells in HIV/SIV Infection
FP7 (2007 to 2013) · 2009–2012 · Project on CORDIS ↗
€181ktheir share - PEMPHIGUSPartner
Pemphigus - From autoimmunity to disease
FP7 (2007 to 2013) · 2008–2011 · Project on CORDIS ↗
€308ktheir share - IMECSPartner
Identification of Mechanisms Correlating with Susceptibility for Avian Influenza
FP7 (2007 to 2013) · 2008–2012 · Project on CORDIS ↗
€388ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Academisch Ziekenhuis LeidenNetherlands · 7 shared projects
- Centre National de la Recherche Scientifique CNRSFrance · 6 shared projects
- The Chancellor, Masters and Scholars of the University of OxfordUnited Kingdom · 6 shared projects
- Commissariat A L Energie Atomique et aux Energies AlternativesFrance · 5 shared projects
- Institut National de la Sante et de la Recherche MedicaleFrance · 5 shared projects
- Universitat ZurichSwitzerland · 5 shared projects
- Istituto Superiore di SanitaItaly · 5 shared projects
- Max-Planck-Gesellschaft zur Forderung der Wissenschaften eVGermany · 4 shared projects
- Karolinska InstitutetSweden · 4 shared projects
- Erasmus Universitair Medisch Centrum RotterdamNetherlands · 4 shared projects
- Institut PasteurFrance · 4 shared projects
- University of GlasgowUnited Kingdom · 4 shared projects
- Imperial College of Science Technology and MedicineUnited Kingdom · 3 shared projects
- University College LondonUnited Kingdom · 3 shared projects
- Universiteit UtrechtNetherlands · 3 shared projects
- Universitetet i OsloNorway · 3 shared projects
Fields it works in
Research fields recorded on its Horizon projects.
- DNA
- HIV
- amines
- antivirals
- autoimmune diseases
- bacteriology
- biosensors
- breast cancer
- cell biology
- cell signaling
- cells technologies
- chromosomes
- coronaviruses
- databases
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗
